These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

894 related items for PubMed ID: 11441521

  • 1. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M.
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence.
    Unger T, Culman J, Gohlke P.
    J Hypertens Suppl; 1998 Sep; 16(7):S3-9. PubMed ID: 9855025
    [Abstract] [Full Text] [Related]

  • 3. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S, Unger T.
    Drugs; 2002 Sep; 62 Spec No 1():43-52. PubMed ID: 12036388
    [Abstract] [Full Text] [Related]

  • 4. Physiologic and pharmacologic implications of AT1 versus AT2 receptors.
    Chung O, Stoll M, Unger T.
    Blood Press Suppl; 1996 Sep; 2():47-52. PubMed ID: 8913540
    [Abstract] [Full Text] [Related]

  • 5. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [Abstract] [Full Text] [Related]

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 7. The role of angiotensin II receptors and their antagonists in hypertension.
    van Zwieten PA.
    Ann Ital Med Int; 2000 Sep; 15(1):85-91. PubMed ID: 10842896
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II type 1 receptor blockade: a novel therapeutic concept.
    Johnston CI.
    Blood Press Suppl; 2000 Sep; 1():9-13. PubMed ID: 11059629
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin receptors in the cardiovascular system.
    Wagenaar LJ, Voors AA, Buikema H, van Gilst WH.
    Can J Cardiol; 2002 Dec; 18(12):1331-9. PubMed ID: 12518185
    [Abstract] [Full Text] [Related]

  • 11. [AT1 angiotensin receptor inhibition as a new therapeutic possibility].
    Hunyady L, Nagy L.
    Orv Hetil; 1997 Oct 12; 138(41):2583-90. PubMed ID: 9411327
    [Abstract] [Full Text] [Related]

  • 12. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders.
    Fyhrquist F, Metsärinne K, Tikkanen I.
    J Hum Hypertens; 1995 Nov 12; 9 Suppl 5():S19-24. PubMed ID: 8583476
    [Abstract] [Full Text] [Related]

  • 13. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK, Sodhi RK, Singh M.
    Life Sci; 2007 Aug 02; 81(8):615-39. PubMed ID: 17692338
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE, McKinnie JJ, Greenberg SS, Giles TD.
    Prog Cardiovasc Dis; 1999 Aug 02; 41(4):265-300. PubMed ID: 10362349
    [Abstract] [Full Text] [Related]

  • 15. How to explain the differences between renin angiotensin system modulators.
    Levy BI.
    Am J Hypertens; 2005 Sep 02; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [Abstract] [Full Text] [Related]

  • 16. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE, Julius S.
    Am Heart J; 2004 Nov 02; 148(5):747-54. PubMed ID: 15523303
    [Abstract] [Full Text] [Related]

  • 17. From converting enzyme inhibition to angiotensin II receptor blockade: new insight on angiotensin II receptor subtypes in the kidney.
    Wolf G, Neilson EG.
    Exp Nephrol; 1996 Nov 02; 4 Suppl 1():8-19. PubMed ID: 9001892
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP, Ruffolo RR.
    J Hypertens Suppl; 1999 Jun 02; 17(2):S27-32. PubMed ID: 10465064
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II AT2 subtype receptors: an emerging target for cardiovascular therapy.
    Volpe M, De Paolis P.
    Ital Heart J; 2000 Feb 02; 1(2):96-103. PubMed ID: 10730608
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II--receptor subtypes characterization and pathophysiological implications.
    Gulati K, Lall SB.
    Indian J Exp Biol; 1996 Feb 02; 34(2):91-7. PubMed ID: 8641721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.